Dr Thomas Ramdahl Joins Clarity Pharmaceuticals` Board
(WorldNews Health)

SYDNEY, March 25, 2019 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is delighted to announce that Dr Thomas Ramdahl will join Clarity`s Board. Dr Ramdahl is a pharmaceutical executive with more than 20 years of clinical and development experience. In 2001, he became President and the first CEO of Algeta ASA (Algeta), a Norwegian biotech company that was successful in researching, developing and launching a radiopharmaceutical for prostate cancer. When Dr Ramdahl joined Algeta, he was one of six employees at the time, and he...